Camilo Félix

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

Paul Moayyedi, John W. Eikelboom, Jackie Bosch et al. · Gastroenterology · 2019 · 469 citations · Full text

Drug Safety, Patient Safety, Pharmacology +6

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

Marjan Walli-Attaei, Philip Joseph, Annika Rosengren et al. · The Lancet · 2020 · 316 citations

Cardiovascular Disease Incidence, Epidemiological Trend, Cardiovascular Epidemiology +14

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

Paul Moayyedi, John W. Eikelboom, Jackie Bosch et al. · Gastroenterology · 2019 · 149 citations · Full text

Drug Safety, Prevent Gastroduodenal Events, Rivaroxaban And/or Aspirin +9